The Scleroderma Research Foundation Science Workshop
Making Strategic Investments Targeting a Complex Disease
After the workshop, through careful selection of submitted proposals and focused engagement of experts in disparate areas of science and medicine, our advisors recommend funding that results in a diverse portfolio of projects spanning multiple disciplines and facets of scleroderma research.
When building a well-rounded portfolio of projects, the SRF works closely with our Scientific Advisory Board to evaluate how each project can address one or more of the following objectives:
- Understanding Who Gets Scleroderma (Genetics and Epigenetics of Susceptibility)
- Unraveling How Scleroderma Progresses (Pathobiology of Initiation, Propagation, and Regulation
- Helping Find a Cure (Enabling the Development of Patient-Specific Medicine)
Realizing a Vision for a World Without Scleroderma
We are entering one of the most promising periods in the history of scleroderma research. Technologies that once seemed aspirational—including single-cell molecular profiling, advanced computational biology, and artificial intelligence—are now transforming how researchers understand disease mechanisms and identify therapeutic opportunities.
Because of our strategic investments, the SRF is uniquely positioned to ensure these advances translate into meaningful progress for people living with scleroderma.